A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease
Clinical trial NCT05792163 · COMPLETED
Trial details
- NCT number
- NCT05792163
- Sponsor
- SciNeuro
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2023-11-29
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.